首页> 外文OA文献 >Agomelatine Treatment of Major Depressive Disorder in Parkinson’s Disease: A Case Series

【2h】

Agomelatine Treatment of Major Depressive Disorder in Parkinson’s Disease: A Case Series

机译：阿戈美拉汀治疗帕金森病严重抑郁症的病例系列

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Domenico De Berardis; Ph. D; Michele Fornaro M. D; Nicola Serroni M. D; Luigi Olivieri M. D; Stefano Marini M. D; Francesco Saverio Moschetta; Maurizio Assetta M. D; Alessandro Valchera M. D; Marco Onofrj M. D; Massimo Di Giannantonio;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Agomelatine treatment of major depressive disorder in Parkinson's disease: a case series. [J] . Domenico De Berardis, Michele Fornaro, Nicola Serroni, The Journal of neuropsychiatry and clinical neurosciences . 2013,第4期

机译：阿戈美拉汀治疗帕金森氏病主要抑郁症的病例系列。
2. What combinations of agomelatine with other antidepressants could be successful during the treatment of major depressive disorder or anxiety disorders in clinical practice? [J] . Petr Potmě?il Therapeutic advances in psychopharmacology. . 2019,第1期

机译：在临床实践中治疗主要抑郁症或焦虑症期间，胍葡萄酒与其他抗抑郁药的组合可能是成功的吗？
3. Efficacy and tolerability of vortioxetine versus agomelatine, categorized by previous treatment, in patients with major depressive disorder switched after an inadequate response [J] . Papakostas George I, Nielsen Rebecca Z., Dragheim Marianne, Journal of psychiatric research . 2018,第期

机译：在响应不充分的反应后，在重大抑郁症的患者中，vortioxetine与阿米甲兰的疗效和耐受性。
4. Counseling as Treatment for Major Depressive Disorder (MDD) in a Woman Participating Radical Organization: A Case Study [C] . Hasna Nadira, Indira Primasari International Conference on Intervention and Applied Psychology . 2019

机译：作为一个妇女参与激进组织的主要抑郁障碍（MDD）的治疗咨询：一个案例研究
5. Genetic Biomarkers of Psychiatric Disease: Discriminating Bipolar Disorder from Major Depressive Disorder with Polygenic Risk Scores [D] . ?Liebers, David T. 2020

机译：精神疾病的遗传生物标志物：鉴别多种抑郁症与多种子基风险评分的双相情感障碍
6. What combinations of agomelatine with other antidepressants could be successful during the treatment of major depressive disorder or anxiety disorders in clinical practice? [O] . Petr Potměšil 2019

机译：在临床实践中重度抑郁症或焦虑症的治疗期间阿戈美拉汀与其他抗抑郁药的哪些组合可能成功？
7. A study to determine the maintenance of efficacy of agomelatine to prevent relapse in out-patients with major depressive disorder. A 8 to 10 weeks open period treatment with agomelatine followed by 24 weeks randomised double-blind period, placebo-controlled, parallel groups and 20 weeks of optional double-blind treatment period. [O] . Frederic Rouillon 2013

机译：一项研究，以确定治疗杂种碱疗效以防止患有重症抑郁症的患者复发。 AGOMELATINE的8至10周的开放期治疗，然后是24周随机化双盲期，安慰剂控制，平行组和20周的可选双盲治疗期。

Agomelatine Treatment of Major Depressive Disorder in Parkinson’s Disease: A Case Series

著录项

引文网络

相似文献

相关主题

期刊订阅